Sarepta Gets An Upgrade; Cardiac, Pulmonary Function Could Provide Added Clinical Support For Exondys
April 05, 2017 at 09:05 AM EDT
Sarepta Therapeutics Inc (NASDAQ: SRPT) presented encouraging long-term cardiac and pulmonary data at the MDA Scientific Conference. The ...